Telmisartan

CAS 144701-48-4 40 current records 14 historicalSmall Molecule

Who holds supplier records for Telmisartan? 40 organisations hold a current record for Telmisartan: an active US FDA Type II Drug Master File or a CEP. A further 14 organisations have only historical (inactive) DMF filings. 30 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (27), China (6), Spain (3), Slovenia (2) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Telmisartan: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/telmisartan

Reading the evidence

  • 40 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    27 of the 39 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 17 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (40)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Telmisartan. Country is the organisation's recorded country, not necessarily the manufacturing site.

India27China6Spain3Slovenia2Netherlands1Country not recorded for 1
Need Telmisartan sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (30)

Certificates of Suitability on the EDQM register for Telmisartan, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 54 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HETERO LABS LIMITED HyderabadIN
CEP 2022-041 - Rev 01
Telmisartan
Nov 2026—
K. P. MANISH GLOBAL INGREDIENTS PRIVATE LIMITED CuddaloreIN
CEP 2024-301 - Rev 01
Telmisartan
Oct 2026—
KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mestoSI
CEP 2021-280 - Rev 01
Telmisartan, 315780
Aug 2026Inspected Jul 2025
Slovenia
MANKIND PHARMA LIMITED New DelhiIN
CEP 2025-135 - Rev 00
Telmisartan, Non-micronised and micronised
Aug 2026—
MSN PHARMACHEM PRIVATE LIMITED SangareddyIN
CEP 2009-108 - Rev 05
Telmisartan, Micronised and non-micronised
Jul 2026—
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2018-104 - Rev 02
Telmisartan
Jul 2026—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2021-194 - Rev 03
Telmisartan, Process II
Jul 2026Inspected May 2026
Italy
VASUDHA PHARMA CHEM LIMITED HyderabadIN
CEP 2024-216 - Rev 00
Telmisartan
Jun 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2008-256 - Rev 06
Telmisartan
Jun 2026—
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2022-047 - Rev 03
Telmisartan, Process II
May 2026—
MICRO LABS LIMITED BengaluruIN
CEP 2020-388 - Rev 03
Telmisartan, Process-II
Mar 2026—
VERDANT LIFE SCIENCES PRIVATE LIMITED AnakapalliIN
CEP 2022-366 - Rev 01
Telmisartan
Feb 2026Inspected Oct 2024
Germany
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2020-290 - Rev 03
Telmisartan, Site II
Sept 2025—
RAGHAVA LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2024-253 - Rev 00
Telmisartan
Aug 2025—
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2025-215 - Rev 00
Telmisartan, Process II
Aug 2025—
TAPI NL B.V. AmsterdamNL
CEP 2010-301 - Rev 05
Telmisartan
Jul 2025—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2009-229 - Rev 02
Telmisartan
Jul 2025—
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2024-457 - Rev 01
Telmisartan, WT6 process
Jun 2025—
GLOCHEM INDUSTRIES PRIVATE LIMITED HyderabadIN
CEP 2023-340 - Rev 00
Telmisartan
Dec 2024—
ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Sanzao TownCN
R0-CEP 2022-179 - Rev 00
Telmisartan
Aug 2023—
KRKA, d.d., Novo mesto Novo mestoSI
R1-CEP 2015-307 - Rev 01
Telmisartan
May 2023—
Moehs Iberica S.L. RubiES
R1-CEP 2012-266 - Rev 02
Telmisartan
Jan 2023—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2010-165 - Rev 03
Telmisartan
Nov 2022—
JUBILANT PHARMOVA LIMITED NanjangudIN
R1-CEP 2011-209 - Rev 01
Telmisartan
Aug 2022—
ZYDUS LIFESCIENCES LIMITED VadodaraIN
R1-CEP 2009-235 - Rev 02
Telmisartan
Jul 2022—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
R1-CEP 2008-217 - Rev 07
Telmisartan
May 2022—
TORRENT PHARMACEUTICALS LIMITED Village BhatIN
R1-CEP 2011-256 - Rev 02
Telmisartan
Sept 2020—
AGC PHARMA CHEMICALS EUROPE S.L.U. Malgrat De MarES
R1-CEP 2009-054 - Rev 03
Telmisartan
Dec 2019—
Interquim, S.A. Sant Cugat Del VallèsES
R1-CEP 2010-363 - Rev 00
Telmisartan
Feb 2019—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
R1-CEP 2011-072 - Rev 00
Telmisartan
May 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (14)

Organisations whose Type II DMFs for Telmisartan are no longer active. These show a past filing, not current supply.

Show all 14 historical records
  • India · Inactive DMF 31823 · filed Aug 2017
  • India · Inactive DMF 26536 · filed Oct 2012
  • India · Inactive DMF 26028 · filed May 2012
  • SIGNA SA DE CV
    Inactive DMF 25742 · filed Jan 2012
  • Italy · Inactive DMF 24703 · filed May 2011
  • India · Inactive DMF 24638 · filed Mar 2011
  • India · Inactive DMF 24472 · filed Jan 2011
  • Jiangxi Synergy Pharmaceutical Co., Ltd
    China · Inactive DMF 24211 · filed Sept 2010
  • SEQUEL PHARMACHEM PRIVATE LTD
    Inactive DMF 22768 · filed May 2009
  • India · Inactive DMF 22443 · filed Jan 2009
  • Amino Chemicals Ltd
    Malta · Inactive DMF 20882 · filed Sept 2007
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 20571 · filed Jun 2007
  • India · Inactive DMF 20575 · filed May 2007
  • India · Inactive DMF 18759 · filed Sept 2005

Overview

Telmisartan is an angiotensin II receptor antagonist used in the treatment of hypertension. It may also reduce the risk of cardiovascular events in patients with high cardiovascular risk.

Chemical identity

IUPAC name
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
Canonical SMILES
CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
InChIKey
RMMXLENWKUUMAY-UHFFFAOYSA-N
Synonyms
Micardis API, bibr 277 se, bibr-277, bibr-277 se, bibr-277-se, c09ca07, kinzalkomb component telmisartan, kinzalmono, micardis, micardis hct component telmisartan, micardisplus component telmisartan, onduarp component telmisartan

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Angiotensin 2 Receptor Blocker
Mechanism of action
Angiotensin 2 Receptor Antagonists

Therapeutic areas

CardiovascularHypertension

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Telmisartan?

40 organisations hold an active US FDA Type II Drug Master File or a CEP for Telmisartan: Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India), GLOCHEM INDUSTRIES LTD (India), Ipca Laboratories Limited (India) and Macleods Pharmaceuticals Ltd. (India), and 32 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Telmisartan Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 20285), ALIVUS LIFE SCIENCES LTD (DMF 27804), APITORIA PHARMA PRIVATE LTD (DMF 25810), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 33989), Dr. Reddy's Laboratories Ltd. (DMF 19759, 23472), GLOCHEM INDUSTRIES LTD (DMF 38772), Ipca Laboratories Limited (DMF 27946) and Macleods Pharmaceuticals Ltd. (DMF 24564) and 19 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Telmisartan records mean?

14 organisations have only inactive Type II DMFs for Telmisartan. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Telmisartan have a European Certificate of Suitability?

Yes. 30 organisations hold a valid CEP for Telmisartan on the EDQM register, including HETERO LABS LIMITED Hyderabad (IN), K. P. MANISH GLOBAL INGREDIENTS PRIVATE LIMITED Cuddalore (IN), KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto (SI), MANKIND PHARMA LIMITED New Delhi (IN), MSN PHARMACHEM PRIVATE LIMITED Sangareddy (IN) and CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram (IN) and 24 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Telmisartan supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Telmisartan?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.